Try it
Pharmacology · Pharmacodynamics: competitive antagonism
Sample itemA reversible competitive antagonist is added to a tissue preparation and the agonist dose-response curve is repeated. What change is expected?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Parallel rightward shift with the same maximal response
A reversible competitive antagonist occupies the same site as the agonist, so more agonist is needed to achieve a given effect. The curve shifts to the right in parallel (higher EC50), and the maximal response is unchanged because a high agonist concentration can overcome the block. An irreversible or non-competitive antagonist lowers the maximum.
Option by option
A. No shift but a flattened curve with a lower slope
A reversible competitive antagonist changes position of the curve rather than flattening it.
B. Parallel rightward shift with the same maximal response (correct)
Correct. Surmountable antagonism raises the EC50 but not the Emax.
C. Rightward shift with a reduced maximal response
A reduced maximum is the signature of irreversible or non-competitive antagonism.
D. Leftward shift with the same maximal response
A leftward shift would indicate increased potency, as with a positive modulator.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?